Why Measles Is Spreading Again and Who Faces the Highest Risk
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for community safety.
University of California San Francisco
This Anti-CRISPR Stops the Protein Assembly Line in Bacteria
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
In the Face of Cuts, W.M. Keck Foundation Supports Vital Research
Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to sustain promising early-career scientists and their trainees during the current period of uncertainty in federal research funding.
How UCSF Teams with Oakland Mayor, Faith Leaders to Stop Violence
Attendees at a community breakfast for Oakland faith leaders hosted by Nicholas Holmes and Oakland Mayor Lee discussed youth violence prevention initiatives and other community topics.
2026 Alumni Awards Recognize Visionary Leaders Shaping the Future of Health
The Alumni Association of UCSF (AAUCSF) announced the recipients of the 2026 UCSF Alumni Achievement Awards, recognizing outstanding alumni from UCSF’s schools.
UC Regents Approve New UCSF Bakar Ear & Hearing Institute
The University of California Board of Regents approved plans for the UCSF Bakar Ear & Hearing Institute, a new, state-of-the-art ear facility at UCSF’s Mission Bay campus, taking the first step to creating one of the world’s leading centers for advancing research and care for hearing and balance disorders.
UCSF Community Honors Life of Doris Fisher (1931 – 2026)
Doris Fisher, a visionary philanthropist and longtime champion of UCSF who passed away in May 2026, devoted more than four decades to advancing the university’s mission. She served as a Lifetime Director on the UCSF Foundation Board and played a key role in building the UCSF Foundation.
Are Your Meds and DNA a Bad Match? This Test Alerts Clinicians
UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right drug and dose for every patient.
Can Blockbuster GLP-1 Weight-Loss Drugs Also Protect Brain Health?
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
One Dose of Psilocybin Changes the Human Brain
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.